Deininger, M <br/><br/>
Chemotherapy for mobilisation of Ph-negative progenitor cells from patients with CML: impact of different mobilisation regimens.  [electronic resource] 

 -  Bone marrow transplantation  Jun 2001 
 - 1125-32 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1703057  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Cyclophosphamide--administration & dosage<br/>Cytarabine--administration & dosage<br/>Female<br/>Graft Survival--drug effects<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Stem Cell Mobilization--methods<br/>Humans<br/>Idarubicin--administration & dosage<br/>Interferon-alpha--administration & dosage<br/>Leukapheresis--standards<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Middle Aged<br/>Philadelphia Chromosome